Subscribe Us

header ads

Recents

header ads

Minimally Invasive Surgical Instruments Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - February 02, 2023

According to the research report, the global minimally invasive surgical instruments market size is expected to touch USD 70 Billion by 2030, from USD 30.72 Billion in 2022, growing with a significant CAGR of 10.84% from 2022 to 2030. 

Minimally Invasive Surgical Instruments Market Size 2021 to 2030


The minimally invasive surgical instruments report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global minimally invasive surgical instruments in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global minimally invasive surgical instruments market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global minimally invasive surgical instruments during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1706

 Report Scope of the Minimally Invasive Surgical Instruments Market

Report CoverageDetails
Market Size by 2030USD 70 Billion
Growth Rate from 2022 to 2030

CAGR of 10.84%

North America Market Share in 202144%
Orthopedic Segment Hit The Revenue Share in 202125%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredDevice, Application, End Use, Geography

This study covers a detailed segmentation of the global minimally invasive surgical instruments market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global minimally invasive surgical instruments market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • The Johns Hopkins Hospital
  • Apollo Hospitals Enterprise Ltd.
  • The General Hospital Corporation
  • Bedfordshire Hospitals
  • Stanford Healthcare
  • Circle Health Ltd.
  • Singapore General Hospital Ltd.
  • Manipal Health Enterprises Pvt. Ltd
  • Mount Elizabeth Hospital
  • King Fahd Medical City 

Market Segmentation

 By Device

  • Handheld Instruments
    • Graspers
    • Retractors/Elevators
    • Suturing Instruments
    • Dilators
    • Other
  • Inflation Devices
    • Balloons
    • Balloon Inflation Devices
  • Surgical Scope
    • Laparoscopes
    • Urology Endoscopes
    • Arthroscopes
    • Neuroendoscopes
    • Other
  • Cutter Instruments
    • Trocars
    • Other Cutting Instruments
  • Guiding Devices
    • Guiding Catheters
    • Guidewires
  • Electrosurgical Devices
    • Electrosurgical Instruments
    • Electrocautery Device
  • Auxiliary Devices
  • Monitoring and Visualization Devices

By Application

  • Cardiac
  • Gastrointestinal
  • Orthopedic
  • Vascular
  • Gynecological
  • Urological
  • Thoracic
  • Cosmetic
  • Dental
  • Others

By End Use

  • Hospitals
  • Ambulatory Surgical Centers

 By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global minimally invasive surgical instruments report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global minimally invasive surgical instruments market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Minimally Invasive Surgical Instruments Market 

5.1. COVID-19 Landscape: Minimally Invasive Surgical Instruments Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Minimally Invasive Surgical Instruments Market, By Device

8.1. Minimally Invasive Surgical Instruments Market, by Device, 2022-2030

8.1.1 Handheld Instruments

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Inflation Devices

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Surgical Scope

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Cutter Instruments

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Guiding Devices

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Electrosurgical Devices

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Auxiliary Devices

8.1.7.1. Market Revenue and Forecast (2017-2030)

8.1.8. Monitoring and Visualization Devices

8.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Minimally Invasive Surgical Instruments Market, By Application

9.1. Minimally Invasive Surgical Instruments Market, by Application, 2022-2030

9.1.1. Cardiac

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Gastrointestinal

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Orthopedic

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Vascular

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Gynecological

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.5. Urological

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.6. Thoracic

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.7. Cosmetic

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Dental

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Others

9.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Minimally Invasive Surgical Instruments Market, By End Use 

10.1. Minimally Invasive Surgical Instruments Market, by End Use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Minimally Invasive Surgical Instruments Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Device (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End Use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Device (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Device (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Device (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Device (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Device (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Device (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Device (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Device (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Device (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Device (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 12. Company Profiles

12.1. The Johns Hopkins Hospital

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Apollo Hospitals Enterprise Ltd.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. The General Hospital Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bedfordshire Hospitals

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Stanford Healthcare

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Circle Health Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Singapore General Hospital Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Manipal Health Enterprises Pvt. Ltd

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Mount Elizabeth Hospital

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. King Fahd Medical City

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments